Susquehanna International Group, LLP Roivant Sciences Ltd. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$10.17 - $12.5 $811,566 - $997,500	-79,800 Reduced 13.95%	492,100 $5.68 Million
Q2 2024 Aug 15, 2024	SELL	$10.36 - $11.74 $203,056 - $230,104	-19,600 Reduced 3.31%	571,900 $6.04 Million
Q1 2024 May 07, 2024	SELL	$9.87 - $11.8 $2.4 Million - $2.87 Million	-243,000 Reduced 29.12%	591,500 $6.23 Million
Q4 2023 Feb 14, 2024	BUY	$8.38 - $11.58 $5.53 Million - $7.64 Million	659,600 Added 377.13%	834,500 $9.37 Million
Q3 2023 Nov 14, 2023	BUY	$9.76 - $13.19 $843,264 - $1.14 Million	86,400 Added 97.63%	174,900 $2.04 Million
Q2 2023 Aug 11, 2023	BUY	$7.09 - $10.08 $421,146 - $598,752	59,400 Added 204.12%	88,500 $892,000
Q1 2023 May 16, 2023	BUY	$6.92 - $9.98 $58,820 - $84,830	8,500 Added 41.26%	29,100 $214,000
Q4 2022 Feb 14, 2023	SELL	$3.36 - $7.99 $18,816 - $44,744	-5,600 Reduced 21.37%	20,600 $164,000
Q3 2022 Nov 14, 2022	SELL	$0.51 - $4.84 $12,189 - $115,676	-23,900 Reduced 47.7%	26,200 $84,000

310

507M

1.26M

2.52M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.45B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.